Cognition Therapeutics, Inc. (CGTX) ownership: Top institutional holder: BIOS Capital Management, LP ($4.56M). Insider activity: Net Buyer (11 buys, 9 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BIOS Capital Management, LP | 6000000.00 | $4.56M | 2026-03-31 |
| VANGUARD GROUP INC | 3317525.00 | $4.48M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3001787.00 | $2.28M | 2026-03-31 |
| DAVENPORT & Co LLC | 2892808.00 | $2.20M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1117136.00 | $848465.00 | 2026-03-31 |
| Chescapmanager LLC | 997029.00 | $757244.00 | 2026-03-31 |
| BlackRock, Inc. | 968362.00 | $735472.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 920208.00 | $699234.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-01 | |
| Buy | null | 2026-05-01 | |
| Sell | null | 2026-04-16 | |
| Buy | null | 2026-04-16 | |
| Buy | null | 2026-04-16 | |
| Buy | null | 2026-04-16 | |
| Sell | null | 2026-04-16 | |
| Sell | null | 2026-04-16 |
Back to CGTX overview · CGTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.